Brooks Laboratories Ltd.

The PE ratio of Brooks Laboratories Ltd. is -15.70 as of December 11, 2023.The PE ratio measures the current share price relative to the earnings of the company for past 12 months (as of last reported period).

The trailing twelve month (TTM) PB ratio of Brooks Laboratories Ltd. is 4.20 as of December 11, 2023. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

Brooks Laboratories Ltd. reported an ROE of -28.26% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Brooks Laboratories Ltd., Promoter held 63.6%, and the public held 33.9% of the total shares.

You can easily buy shares of Brooks Laboratories Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

The fair value of Brooks Laboratories Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.